Found: 80
Select item for more details and to access through your institution.
Hodgkin's Lymphoma in Younger Patients: Lessons Learned on the Road to Success.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 4, p. 434
- By:
- Publication type:
- Article
Chemotherapy With Dexamethasone, High-Dose Cytarabine, and Cisplatin for Parenchymal Brain Lymphoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 17, p. 1408, doi. 10.1093/jnci/80.17.1408
- By:
- Publication type:
- Article
Acral Necrotizing Mycosis Fungoides.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 2, p. 146
- By:
- Publication type:
- Article
Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma.
- Published in:
- Annals of Internal Medicine, 1991, v. 114, n. 10, p. 855, doi. 10.7326/0003-4819-114-10-855
- By:
- Publication type:
- Article
Incidence of lymphoma in the US classified by the working formulation.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Combined modality therapy in Stage III and Stage IIIE diffuse large cell lymphomas.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Diagnosis and management of Hodgkin's disease in the adult.
- Published in:
- Cancer (0008543X), 1983, v. 51, n. S12, p. 2469, doi. 10.1002/1097-0142(19830615)51:12+<2469::AID-CNCR2820511315>3.0.CO;2-4
- By:
- Publication type:
- Article
Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Reassessment of prognostic factors in stage IIIA and IIIB Hodgkin's disease treated with MOPP and radiotherapy.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 35, doi. 10.1111/bjh.18441
- By:
- Publication type:
- Article
Lenalidomide plus rituximab (R<sup>2</sup>) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 874, doi. 10.1111/bjh.15843
- By:
- Publication type:
- Article
Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 670, doi. 10.1111/bjh.15814
- By:
- Publication type:
- Article
Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 545, doi. 10.1111/bjh.15054
- By:
- Publication type:
- Article
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 851, doi. 10.1111/bjh.14267
- By:
- Publication type:
- Article
Dose adjusted- EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 503, doi. 10.1111/bjh.14226
- By:
- Publication type:
- Article
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R- FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 263, doi. 10.1111/bjh.14541
- By:
- Publication type:
- Article
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 750, doi. 10.1111/bjh.14477
- By:
- Publication type:
- Article
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 2, p. 290, doi. 10.1111/bjh.14237
- By:
- Publication type:
- Article
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 80, doi. 10.1111/bjh.13796
- By:
- Publication type:
- Article
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 726, doi. 10.1111/bjh.13659
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 814, doi. 10.1111/bjh.13367
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 177, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 6, p. 891, doi. 10.1111/bjh.12982
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 891, doi. 10.1111/bjh.12982
- By:
- Publication type:
- Article
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 112, doi. 10.1111/bjh.12715
- By:
- Publication type:
- Article
Prospective phase II study of rituximab with alternating cycles of hyper- CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 611, doi. 10.1111/bjh.12585
- By:
- Publication type:
- Article
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 1, p. 138, doi. 10.1111/bjh.12326
- By:
- Publication type:
- Article
Long term results of a phase 2 study of vincristine sulfate liposome injection ( Marqibo<sup>®</sup>) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non- Hodgkin lymphomas
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 631, doi. 10.1111/bjh.12446
- By:
- Publication type:
- Article
Maintenance and Consolidation Strategies in Non-Hodgkin's Lymphoma: A Review of the Data.
- Published in:
- Current Oncology Reports, 2010, v. 12, n. 6, p. 395, doi. 10.1007/s11912-010-0128-x
- By:
- Publication type:
- Article
Dose-Related Safety and Immunogenicity of Baculovirus-Expressed Trivalent Influenza Vaccine: A Double-Blind, Controlled Trial in Adult Patients with Non-Hodgkin B Cell Lymphoma.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 10, p. 1394, doi. 10.1086/508493
- By:
- Publication type:
- Article
Ibrutinib-associated Serositis in Mantle Cell Lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5627, doi. 10.3390/cancers13225627
- By:
- Publication type:
- Article
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Surgical debulking is associated with improved survival in stage I-II diffuse large cell lymphoma.
- Published in:
- Cancer (0008543X), 1990, v. 66, n. 2, p. 267, doi. 10.1002/1097-0142(19900715)66:2<267::AID-CNCR2820660213>3.0.CO;2-N
- By:
- Publication type:
- Article
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Role of the gallium scan in Hodgkin's disease.
- Published in:
- 1990
- By:
- Publication type:
- journal article
The Effect of Zoledronic Acid on the Prevention of Bone Loss in Lymphoma Patients Receiving First-line Therapy.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E30, doi. 10.3816/CLM.2009.n.092
- By:
- Publication type:
- Article
Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia.
- Published in:
- Drugs, 2010, v. 70, n. 3, p. 261, doi. 10.2165/11532180-000000000-00000
- By:
- Publication type:
- Article
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 99, doi. 10.1016/j.clml.2012.11.002
- By:
- Publication type:
- Article
The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 15, doi. 10.1016/j.clml.2012.09.009
- By:
- Publication type:
- Article
Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E32, doi. 10.3816/CLML.2010.n.042
- By:
- Publication type:
- Article
Phase 2 Study of Gemcitabine in Combination With Rituximab in Patients With Recurrent or Refractory Hodgkin Lymphoma.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 4, p. 831, doi. 10.1002/cncr.23237
- By:
- Publication type:
- Article
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Hodgkin transformation of chronic lymphocytic leukemia: The M. D. Anderson Cancer Center experience.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 6, p. 1294
- By:
- Publication type:
- Article
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 7, p. 1569
- By:
- Publication type:
- Article
Phase II study of oxaliplatin in patients with recurrent or refractory non‐Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 4, p. 781
- By:
- Publication type:
- Article
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 2, p. 345, doi. 10.1002/cncr.21151
- By:
- Publication type:
- Article